Omixon Signs Letter of Intent with Pronto Diagnostics

At Omixon we are working hard to expand our customer base. Our Holotype HLA kit is already making an impact on the HLA typing market, and we are regularly contacted by companies proposing to partner with us as local distributors. For example, we have recently signed a letter of intent with Pronto Diagnostics and are underway with arranging exclusive distribution for Israel.

pronto_diagnosticsPronto Diagnostics is a leading, Tel-Aviv-based provider of molecular diagnostics products and services with extensive experience in genetic analysis. We are currently defining the terms and conditions of this partnership and we are very confident that Pronto Diagnostics will be an ideal partner for marketing our HLA typing kits in one of the most technologically advanced countries in the world.

For more information about our distributors, click here…